Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
研发技术成果转化289.8M55.19%
临床前药学研究113.32M21.58%
Clinical service92.59M17.63%
Other17.16M3.27%
CDMO5.12M0.98%
权益分成4.55M0.87%
Commercial production2.52M0.48%
View all
Industry
Currency:CNY
2024/H1
Stock NameRevenueRatio
CRO行业517.42M98.55%
CDMO5.12M0.98%
Commercial production2.52M0.48%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Territory525.03M99.99%
Total special adjustments31.3K0.01%